nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP3A4—Temozolomide—malignant glioma	0.4	1	CbGbCtD
Dolasetron—HTR3A—fourth ventricle—malignant glioma	0.131	0.753	CbGeAlD
Dolasetron—Transaminases increased—Carmustine—malignant glioma	0.0113	0.0304	CcSEcCtD
Dolasetron—HTR3A—brainstem—malignant glioma	0.0102	0.059	CbGeAlD
Dolasetron—Influenza-like symptoms—Temozolomide—malignant glioma	0.00927	0.0251	CcSEcCtD
Dolasetron—HTR3A—telencephalon—malignant glioma	0.00908	0.0524	CbGeAlD
Dolasetron—Injection site pain—Carmustine—malignant glioma	0.00839	0.0227	CcSEcCtD
Dolasetron—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00805	0.0218	CcSEcCtD
Dolasetron—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00728	0.0197	CcSEcCtD
Dolasetron—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00662	0.0179	CcSEcCtD
Dolasetron—Influenza like illness—Temozolomide—malignant glioma	0.00643	0.0174	CcSEcCtD
Dolasetron—Aplastic anaemia—Temozolomide—malignant glioma	0.00622	0.0168	CcSEcCtD
Dolasetron—Abnormal vision—Carmustine—malignant glioma	0.00597	0.0162	CcSEcCtD
Dolasetron—Sepsis—Carmustine—malignant glioma	0.00594	0.0161	CcSEcCtD
Dolasetron—Abnormal vision—Temozolomide—malignant glioma	0.00577	0.0156	CcSEcCtD
Dolasetron—Phlebitis—Carmustine—malignant glioma	0.00577	0.0156	CcSEcCtD
Dolasetron—Thrombophlebitis—Carmustine—malignant glioma	0.00574	0.0155	CcSEcCtD
Dolasetron—Thrombophlebitis—Temozolomide—malignant glioma	0.00555	0.015	CcSEcCtD
Dolasetron—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00552	0.0149	CcSEcCtD
Dolasetron—Vascular purpura—Temozolomide—malignant glioma	0.00537	0.0145	CcSEcCtD
Dolasetron—HTR3A—central nervous system—malignant glioma	0.00516	0.0298	CbGeAlD
Dolasetron—Purpura—Temozolomide—malignant glioma	0.00499	0.0135	CcSEcCtD
Dolasetron—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—COX8A—malignant glioma	0.00491	0.0872	CbGpPWpGaD
Dolasetron—Face oedema—Carmustine—malignant glioma	0.0048	0.013	CcSEcCtD
Dolasetron—Ataxia—Carmustine—malignant glioma	0.00468	0.0126	CcSEcCtD
Dolasetron—Face oedema—Temozolomide—malignant glioma	0.00464	0.0125	CcSEcCtD
Dolasetron—Ataxia—Temozolomide—malignant glioma	0.00452	0.0122	CcSEcCtD
Dolasetron—Dehydration—Temozolomide—malignant glioma	0.00447	0.0121	CcSEcCtD
Dolasetron—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00433	0.0117	CcSEcCtD
Dolasetron—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00424	0.0115	CcSEcCtD
Dolasetron—Abdominal distension—Temozolomide—malignant glioma	0.00418	0.0113	CcSEcCtD
Dolasetron—HTR3A—brain—malignant glioma	0.0041	0.0236	CbGeAlD
Dolasetron—Sweating increased—Temozolomide—malignant glioma	0.00405	0.0109	CcSEcCtD
Dolasetron—Dysuria—Temozolomide—malignant glioma	0.00388	0.0105	CcSEcCtD
Dolasetron—Pneumonia—Carmustine—malignant glioma	0.00385	0.0104	CcSEcCtD
Dolasetron—CYP2D6—brainstem—malignant glioma	0.00376	0.0217	CbGeAlD
Dolasetron—Stomatitis—Carmustine—malignant glioma	0.00374	0.0101	CcSEcCtD
Dolasetron—Pneumonia—Temozolomide—malignant glioma	0.00372	0.0101	CcSEcCtD
Dolasetron—Stomatitis—Temozolomide—malignant glioma	0.00361	0.00976	CcSEcCtD
Dolasetron—Oedema peripheral—Carmustine—malignant glioma	0.00339	0.00916	CcSEcCtD
Dolasetron—CYP2D6—telencephalon—malignant glioma	0.00334	0.0193	CbGeAlD
Dolasetron—Visual impairment—Carmustine—malignant glioma	0.00332	0.00896	CcSEcCtD
Dolasetron—Oedema peripheral—Temozolomide—malignant glioma	0.00327	0.00885	CcSEcCtD
Dolasetron—Visual impairment—Temozolomide—malignant glioma	0.0032	0.00866	CcSEcCtD
Dolasetron—Flushing—Carmustine—malignant glioma	0.00319	0.00863	CcSEcCtD
Dolasetron—Tinnitus—Temozolomide—malignant glioma	0.0031	0.00838	CcSEcCtD
Dolasetron—Flushing—Temozolomide—malignant glioma	0.00309	0.00834	CcSEcCtD
Dolasetron—Arrhythmia—Carmustine—malignant glioma	0.00307	0.00831	CcSEcCtD
Dolasetron—Chills—Temozolomide—malignant glioma	0.00298	0.00806	CcSEcCtD
Dolasetron—Dysgeusia—Temozolomide—malignant glioma	0.00283	0.00766	CcSEcCtD
Dolasetron—Tremor—Carmustine—malignant glioma	0.00281	0.00758	CcSEcCtD
Dolasetron—Anaemia—Carmustine—malignant glioma	0.00277	0.00748	CcSEcCtD
Dolasetron—Agitation—Carmustine—malignant glioma	0.00275	0.00744	CcSEcCtD
Dolasetron—Tremor—Temozolomide—malignant glioma	0.00271	0.00733	CcSEcCtD
Dolasetron—Ill-defined disorder—Temozolomide—malignant glioma	0.00269	0.00726	CcSEcCtD
Dolasetron—Anaemia—Temozolomide—malignant glioma	0.00267	0.00723	CcSEcCtD
Dolasetron—Agitation—Temozolomide—malignant glioma	0.00266	0.00719	CcSEcCtD
Dolasetron—Angioedema—Temozolomide—malignant glioma	0.00264	0.00715	CcSEcCtD
Dolasetron—Malaise—Temozolomide—malignant glioma	0.00261	0.00706	CcSEcCtD
Dolasetron—Vertigo—Temozolomide—malignant glioma	0.0026	0.00703	CcSEcCtD
Dolasetron—Convulsion—Carmustine—malignant glioma	0.00259	0.00701	CcSEcCtD
Dolasetron—Hypertension—Carmustine—malignant glioma	0.00259	0.00699	CcSEcCtD
Dolasetron—Palpitations—Temozolomide—malignant glioma	0.00256	0.00691	CcSEcCtD
Dolasetron—Myalgia—Carmustine—malignant glioma	0.00255	0.00689	CcSEcCtD
Dolasetron—Chest pain—Carmustine—malignant glioma	0.00255	0.00689	CcSEcCtD
Dolasetron—Anxiety—Carmustine—malignant glioma	0.00254	0.00687	CcSEcCtD
Dolasetron—Cough—Temozolomide—malignant glioma	0.00253	0.00683	CcSEcCtD
Dolasetron—Convulsion—Temozolomide—malignant glioma	0.00251	0.00678	CcSEcCtD
Dolasetron—Hypertension—Temozolomide—malignant glioma	0.0025	0.00675	CcSEcCtD
Dolasetron—Confusional state—Carmustine—malignant glioma	0.00246	0.00666	CcSEcCtD
Dolasetron—Arthralgia—Temozolomide—malignant glioma	0.00246	0.00666	CcSEcCtD
Dolasetron—Myalgia—Temozolomide—malignant glioma	0.00246	0.00666	CcSEcCtD
Dolasetron—Anxiety—Temozolomide—malignant glioma	0.00246	0.00664	CcSEcCtD
Dolasetron—Oedema—Carmustine—malignant glioma	0.00244	0.00661	CcSEcCtD
Dolasetron—Discomfort—Temozolomide—malignant glioma	0.00243	0.00658	CcSEcCtD
Dolasetron—Dry mouth—Temozolomide—malignant glioma	0.00241	0.00651	CcSEcCtD
Dolasetron—Thrombocytopenia—Carmustine—malignant glioma	0.00239	0.00647	CcSEcCtD
Dolasetron—Tachycardia—Carmustine—malignant glioma	0.00239	0.00645	CcSEcCtD
Dolasetron—Confusional state—Temozolomide—malignant glioma	0.00238	0.00644	CcSEcCtD
Dolasetron—Anaphylactic shock—Temozolomide—malignant glioma	0.00236	0.00639	CcSEcCtD
Dolasetron—Oedema—Temozolomide—malignant glioma	0.00236	0.00639	CcSEcCtD
Dolasetron—Anorexia—Carmustine—malignant glioma	0.00233	0.0063	CcSEcCtD
Dolasetron—Thrombocytopenia—Temozolomide—malignant glioma	0.00231	0.00625	CcSEcCtD
Dolasetron—Hypotension—Carmustine—malignant glioma	0.00228	0.00617	CcSEcCtD
Dolasetron—Hyperhidrosis—Temozolomide—malignant glioma	0.00228	0.00617	CcSEcCtD
Dolasetron—Anorexia—Temozolomide—malignant glioma	0.00225	0.00609	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00223	0.00602	CcSEcCtD
Dolasetron—Paraesthesia—Carmustine—malignant glioma	0.00219	0.00593	CcSEcCtD
Dolasetron—Dyspnoea—Carmustine—malignant glioma	0.00218	0.00589	CcSEcCtD
Dolasetron—Somnolence—Carmustine—malignant glioma	0.00217	0.00587	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00215	0.00582	CcSEcCtD
Dolasetron—Decreased appetite—Carmustine—malignant glioma	0.00212	0.00574	CcSEcCtD
Dolasetron—Paraesthesia—Temozolomide—malignant glioma	0.00212	0.00573	CcSEcCtD
Dolasetron—Dyspnoea—Temozolomide—malignant glioma	0.00211	0.00569	CcSEcCtD
Dolasetron—Somnolence—Temozolomide—malignant glioma	0.0021	0.00568	CcSEcCtD
Dolasetron—CYP2D6—CYP2E1 reactions—CYP2B6—malignant glioma	0.00209	0.0371	CbGpPWpGaD
Dolasetron—Constipation—Carmustine—malignant glioma	0.00209	0.00565	CcSEcCtD
Dolasetron—Pain—Carmustine—malignant glioma	0.00209	0.00565	CcSEcCtD
Dolasetron—Dyspepsia—Temozolomide—malignant glioma	0.00208	0.00562	CcSEcCtD
Dolasetron—CYP2C9—CYP2E1 reactions—CYP2B6—malignant glioma	0.00207	0.0368	CbGpPWpGaD
Dolasetron—Decreased appetite—Temozolomide—malignant glioma	0.00205	0.00555	CcSEcCtD
Dolasetron—Fatigue—Temozolomide—malignant glioma	0.00204	0.0055	CcSEcCtD
Dolasetron—Pain—Temozolomide—malignant glioma	0.00202	0.00546	CcSEcCtD
Dolasetron—Constipation—Temozolomide—malignant glioma	0.00202	0.00546	CcSEcCtD
Dolasetron—Feeling abnormal—Carmustine—malignant glioma	0.00201	0.00544	CcSEcCtD
Dolasetron—Gastrointestinal pain—Carmustine—malignant glioma	0.002	0.0054	CcSEcCtD
Dolasetron—Feeling abnormal—Temozolomide—malignant glioma	0.00195	0.00526	CcSEcCtD
Dolasetron—Abdominal pain—Carmustine—malignant glioma	0.00193	0.00522	CcSEcCtD
Dolasetron—Body temperature increased—Carmustine—malignant glioma	0.00193	0.00522	CcSEcCtD
Dolasetron—Gastrointestinal pain—Temozolomide—malignant glioma	0.00193	0.00522	CcSEcCtD
Dolasetron—CYP3A4—central nervous system—malignant glioma	0.00193	0.0111	CbGeAlD
Dolasetron—CYP2D6—central nervous system—malignant glioma	0.0019	0.0109	CbGeAlD
Dolasetron—Urticaria—Temozolomide—malignant glioma	0.00188	0.00507	CcSEcCtD
Dolasetron—Abdominal pain—Temozolomide—malignant glioma	0.00187	0.00505	CcSEcCtD
Dolasetron—Body temperature increased—Temozolomide—malignant glioma	0.00187	0.00505	CcSEcCtD
Dolasetron—CYP2D6—cerebellum—malignant glioma	0.00185	0.0107	CbGeAlD
Dolasetron—Hypersensitivity—Carmustine—malignant glioma	0.0018	0.00487	CcSEcCtD
Dolasetron—Asthenia—Carmustine—malignant glioma	0.00175	0.00474	CcSEcCtD
Dolasetron—Hypersensitivity—Temozolomide—malignant glioma	0.00174	0.0047	CcSEcCtD
Dolasetron—Asthenia—Temozolomide—malignant glioma	0.00169	0.00458	CcSEcCtD
Dolasetron—Diarrhoea—Carmustine—malignant glioma	0.00167	0.00452	CcSEcCtD
Dolasetron—Pruritus—Temozolomide—malignant glioma	0.00167	0.00452	CcSEcCtD
Dolasetron—CYP2D6—Fatty acids—CYP2B6—malignant glioma	0.00163	0.029	CbGpPWpGaD
Dolasetron—Dizziness—Carmustine—malignant glioma	0.00162	0.00437	CcSEcCtD
Dolasetron—Diarrhoea—Temozolomide—malignant glioma	0.00162	0.00437	CcSEcCtD
Dolasetron—Dizziness—Temozolomide—malignant glioma	0.00156	0.00422	CcSEcCtD
Dolasetron—Rash—Carmustine—malignant glioma	0.00154	0.00417	CcSEcCtD
Dolasetron—Dermatitis—Carmustine—malignant glioma	0.00154	0.00416	CcSEcCtD
Dolasetron—Headache—Carmustine—malignant glioma	0.00153	0.00414	CcSEcCtD
Dolasetron—CYP2D6—Oxidation by Cytochrome P450—POR—malignant glioma	0.00153	0.0271	CbGpPWpGaD
Dolasetron—CYP2C9—Oxidation by Cytochrome P450—POR—malignant glioma	0.00151	0.0269	CbGpPWpGaD
Dolasetron—CYP2D6—brain—malignant glioma	0.00151	0.00869	CbGeAlD
Dolasetron—Rash—Temozolomide—malignant glioma	0.00149	0.00403	CcSEcCtD
Dolasetron—Dermatitis—Temozolomide—malignant glioma	0.00149	0.00402	CcSEcCtD
Dolasetron—Headache—Temozolomide—malignant glioma	0.00148	0.004	CcSEcCtD
Dolasetron—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.00148	0.0262	CbGpPWpGaD
Dolasetron—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—malignant glioma	0.00145	0.0257	CbGpPWpGaD
Dolasetron—HTR3A—Ion channel transport—ATP1B2—malignant glioma	0.00144	0.0256	CbGpPWpGaD
Dolasetron—CYP2D6—Xenobiotics—CYP2B6—malignant glioma	0.0013	0.023	CbGpPWpGaD
Dolasetron—CYP2C9—Xenobiotics—CYP2B6—malignant glioma	0.00128	0.0228	CbGpPWpGaD
Dolasetron—CYP2D6—Xenobiotics—CYP2C18—malignant glioma	0.00112	0.02	CbGpPWpGaD
Dolasetron—CYP2C9—Xenobiotics—CYP2C18—malignant glioma	0.00111	0.0198	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.00102	0.0181	CbGpPWpGaD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.000998	0.0177	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—MYB—malignant glioma	0.000939	0.0167	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.000907	0.0161	CbGpPWpGaD
Dolasetron—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000882	0.0157	CbGpPWpGaD
Dolasetron—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.000847	0.015	CbGpPWpGaD
Dolasetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00084	0.0149	CbGpPWpGaD
Dolasetron—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.000735	0.013	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.000705	0.0125	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.000705	0.0125	CbGpPWpGaD
Dolasetron—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.000689	0.0122	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000627	0.0111	CbGpPWpGaD
Dolasetron—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.000611	0.0108	CbGpPWpGaD
Dolasetron—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000582	0.0103	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.00058	0.0103	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000574	0.0102	CbGpPWpGaD
Dolasetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000554	0.00984	CbGpPWpGaD
Dolasetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000538	0.00956	CbGpPWpGaD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000534	0.00947	CbGpPWpGaD
Dolasetron—CYP2D6—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000531	0.00943	CbGpPWpGaD
Dolasetron—CYP2C9—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000527	0.00935	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000506	0.00898	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000501	0.0089	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—APOD—malignant glioma	0.000488	0.00866	CbGpPWpGaD
Dolasetron—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000467	0.00829	CbGpPWpGaD
Dolasetron—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000463	0.00821	CbGpPWpGaD
Dolasetron—CYP2D6—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000461	0.00818	CbGpPWpGaD
Dolasetron—CYP2C9—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000457	0.00811	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000436	0.00775	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000433	0.00768	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000424	0.00752	CbGpPWpGaD
Dolasetron—CYP2C9—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000406	0.0072	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000378	0.00672	CbGpPWpGaD
Dolasetron—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000377	0.0067	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000375	0.00666	CbGpPWpGaD
Dolasetron—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000374	0.00664	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000352	0.00625	CbGpPWpGaD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000347	0.00617	CbGpPWpGaD
Dolasetron—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000305	0.00542	CbGpPWpGaD
Dolasetron—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000301	0.00535	CbGpPWpGaD
Dolasetron—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000287	0.00509	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000285	0.00506	CbGpPWpGaD
Dolasetron—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000284	0.00505	CbGpPWpGaD
Dolasetron—HTR3A—Ion channel transport—RAF1—malignant glioma	0.000284	0.00505	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.000275	0.00488	CbGpPWpGaD
Dolasetron—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000269	0.00478	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000264	0.00468	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000263	0.00467	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00025	0.00443	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000247	0.00439	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—CYP2B6—malignant glioma	0.000232	0.00411	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.00023	0.00408	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000229	0.00407	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—CYP2B6—malignant glioma	0.000229	0.00406	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.000227	0.00402	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000223	0.00396	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000218	0.00387	CbGpPWpGaD
Dolasetron—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000206	0.00365	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—CYP2C18—malignant glioma	0.000201	0.00357	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.000199	0.00354	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	0.000198	0.00352	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000196	0.00349	CbGpPWpGaD
Dolasetron—HTR3A—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000191	0.0034	CbGpPWpGaD
Dolasetron—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000187	0.00333	CbGpPWpGaD
Dolasetron—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000177	0.00315	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—GSTT1—malignant glioma	0.000163	0.00289	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.000161	0.00286	CbGpPWpGaD
Dolasetron—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000155	0.00276	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—PTGS1—malignant glioma	0.000152	0.0027	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000152	0.00269	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.000151	0.00268	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000149	0.00265	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000131	0.00233	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.00013	0.0023	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—RTEL1—malignant glioma	0.000114	0.00202	CbGpPWpGaD
Dolasetron—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000114	0.00202	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000113	0.002	CbGpPWpGaD
Dolasetron—CYP2D6—Biological oxidations—GSTP1—malignant glioma	0.000113	0.002	CbGpPWpGaD
Dolasetron—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000112	0.00198	CbGpPWpGaD
Dolasetron—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	0.000111	0.00197	CbGpPWpGaD
Dolasetron—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.00011	0.00196	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000106	0.00189	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—PTGS1—malignant glioma	9.96e-05	0.00177	CbGpPWpGaD
Dolasetron—HTR3A—Transmembrane transport of small molecules—RAF1—malignant glioma	9.89e-05	0.00176	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	8.07e-05	0.00143	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7.81e-05	0.00139	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—RTEL1—malignant glioma	7.45e-05	0.00132	CbGpPWpGaD
Dolasetron—CYP3A4—Biological oxidations—GSTP1—malignant glioma	7.37e-05	0.00131	CbGpPWpGaD
Dolasetron—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	7.26e-05	0.00129	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—COX8A—malignant glioma	6.54e-05	0.00116	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—COX8A—malignant glioma	6.49e-05	0.00115	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.8e-05	0.00103	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—ASMT—malignant glioma	5.56e-05	0.000988	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—ASMT—malignant glioma	5.51e-05	0.000979	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.39e-05	0.000957	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—BCAN—malignant glioma	5.23e-05	0.000929	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—BCAN—malignant glioma	5.18e-05	0.000921	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—COX8A—malignant glioma	4.28e-05	0.000759	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—IDH2—malignant glioma	4.22e-05	0.000748	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—IDH2—malignant glioma	4.18e-05	0.000742	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP2B6—malignant glioma	3.96e-05	0.000704	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.94e-05	0.0007	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP2B6—malignant glioma	3.93e-05	0.000698	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—ASMT—malignant glioma	3.64e-05	0.000646	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—IDH1—malignant glioma	3.63e-05	0.000644	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—IDH1—malignant glioma	3.59e-05	0.000638	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SPHK1—malignant glioma	3.51e-05	0.000623	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SPHK1—malignant glioma	3.48e-05	0.000617	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CYP2C18—malignant glioma	3.44e-05	0.00061	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—BCAN—malignant glioma	3.42e-05	0.000607	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CYP2C18—malignant glioma	3.41e-05	0.000605	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.21e-05	0.00057	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.93e-05	0.00052	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.82e-05	0.000501	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTT1—malignant glioma	2.78e-05	0.000493	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—IDH2—malignant glioma	2.76e-05	0.000489	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTT1—malignant glioma	2.76e-05	0.000489	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PTGS1—malignant glioma	2.6e-05	0.000462	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.59e-05	0.00046	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PTGS1—malignant glioma	2.58e-05	0.000458	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.57e-05	0.000457	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—BCHE—malignant glioma	2.42e-05	0.00043	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—BCHE—malignant glioma	2.4e-05	0.000426	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—SLC5A5—malignant glioma	2.39e-05	0.000425	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—SLC5A5—malignant glioma	2.37e-05	0.000421	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—IDH1—malignant glioma	2.37e-05	0.000421	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SPHK1—malignant glioma	2.29e-05	0.000407	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.25e-05	0.000399	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.24e-05	0.000398	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.22e-05	0.000394	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.94e-05	0.000344	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—GSTP1—malignant glioma	1.93e-05	0.000342	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—GSTP1—malignant glioma	1.91e-05	0.000339	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CAT—malignant glioma	1.87e-05	0.000333	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CAT—malignant glioma	1.86e-05	0.00033	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTT1—malignant glioma	1.82e-05	0.000323	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—NCOR1—malignant glioma	1.77e-05	0.000314	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—NCOR1—malignant glioma	1.76e-05	0.000312	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PTGS1—malignant glioma	1.7e-05	0.000302	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—BCHE—malignant glioma	1.58e-05	0.000281	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.56e-05	0.000278	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—CAV1—malignant glioma	1.44e-05	0.000256	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—CAV1—malignant glioma	1.43e-05	0.000254	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.37e-05	0.000243	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.31e-05	0.000233	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.3e-05	0.000231	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PPARG—malignant glioma	1.27e-05	0.000225	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—GSTP1—malignant glioma	1.26e-05	0.000224	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PPARG—malignant glioma	1.26e-05	0.000223	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CAT—malignant glioma	1.23e-05	0.000218	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—NCOR1—malignant glioma	1.16e-05	0.000205	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.16e-05	0.000205	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PIK3CD—malignant glioma	1.15e-05	0.000203	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.01e-05	0.000179	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PIK3CB—malignant glioma	9.99e-06	0.000177	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PTGS2—malignant glioma	9.98e-06	0.000177	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PTGS2—malignant glioma	9.89e-06	0.000176	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—CAV1—malignant glioma	9.44e-06	0.000168	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PTEN—malignant glioma	8.7e-06	0.000155	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PTEN—malignant glioma	8.63e-06	0.000153	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PIK3CG—malignant glioma	8.59e-06	0.000153	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PPARG—malignant glioma	8.3e-06	0.000147	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PIK3CD—malignant glioma	7.56e-06	0.000134	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PIK3CB—malignant glioma	6.59e-06	0.000117	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PTGS2—malignant glioma	6.53e-06	0.000116	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—PIK3CA—malignant glioma	6.14e-06	0.000109	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—PIK3CA—malignant glioma	6.09e-06	0.000108	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PTEN—malignant glioma	5.69e-06	0.000101	CbGpPWpGaD
Dolasetron—CYP2D6—Metabolism—AKT1—malignant glioma	5.02e-06	8.91e-05	CbGpPWpGaD
Dolasetron—CYP2C9—Metabolism—AKT1—malignant glioma	4.97e-06	8.83e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.01e-06	7.13e-05	CbGpPWpGaD
Dolasetron—CYP3A4—Metabolism—AKT1—malignant glioma	3.28e-06	5.82e-05	CbGpPWpGaD
